A Role for β-Cell-Expressed G Protein-Coupled Receptor 119 in Glycemic Control by Enhancing Glucose-Dependent Insulin Release
Zhi‐Liang Chu(Arena Pharmaceuticals (United States)), James Leonard(Arena Pharmaceuticals (United States)), Molly Moloney(Arena Pharmaceuticals (United States)), Graeme Semple(Eurofins (United States)), Robert M. Jones(Arena Pharmaceuticals (United States)), Hongmei He(Arena Pharmaceuticals (United States)), David J. Unett(Arena Pharmaceuticals (United States)), Didier Bagnol(General Atomics (United States)), Dominic P. Behan, Helen Mondala(Arena Pharmaceuticals (United States)), Hui Gao(Shandong Institute of Food and Drug Inspection), Annette Lucman(Arena Pharmaceuticals (United States)), Keith T. Demarest, Yin Liang, Verónica Gutiérrez(Universidad de la República de Uruguay), Christopher J. Carroll(St George's, University of London)
Cited by 294
Related Papers
Anatomy of an Endogenous Antagonist: Relationship between Agouti-Related Protein and Proopiomelanocortin in Brain
|Journal of Neuroscience|1999|427
Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3
|EMBO Molecular Medicine|2014|386
A Role for Intestinal Endocrine Cell-Expressed G Protein-Coupled Receptor 119 in Glycemic Control by Enhancing Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Peptide Release
|Endocrinology|2008|382
Urocortin inhibits Beclin1-mediated autophagic cell death in cardiac myocytes exposed to ischaemia/reperfusion injury
|Journal of Molecular and Cellular Cardiology|2006|312
Mitochondrial myopathy induces a starvation-like response
|Human Molecular Genetics|2010|306